Table 4.
Results of NO release after treatment of different concentration HAPS and APS.
Treatment Groups (μg mL−1) | NO Release Rate/μM | |
---|---|---|
Blank group | 0.84 ± 0.50 ** | |
Inflammation model group | 5.28 ± 0.37 | |
HAPS | 10 | 2.80 ± 0.43 ** |
50 | 2.75 ± 0.66 ** | |
100 | 2.44 ± 1.04 ** | |
300 | 2.06 ± 1.13 ** | |
APS | 10 | 3.92 ± 0.98 ** |
50 | 2.97 ± 0.67 ** | |
100 | 2.81 ± 0.47 ** | |
300 | 2.42 ± 0.23 ** | |
Ibuprofen | 10 | 5.19 ± 0.001 |
50 | 4.87 ± 0.004 | |
100 | 4.27 ± 0.003 * | |
300 | 2.93 ± 0.002 ** |
Data are presented as mean ± S.D. from experiments repeated 6 times. * Indicates the statistical significance of the difference among inflammation model group and blank group, HAPS-treated group, APS-treated group and ibuprofen-treated group (n = 6, * p < 0.05, ** p < 0.01 vs. inflammation model group).